- The European Commission's approval is based on the CHMP positive opinion
- Label update comes in response to new biomarker data obtained from the OPUS study
Merck's (MRK) Keytruda treatment improved the survival rate of patients with bladder cancer who previously underwent treatment.
Look for solid companies showing life.
Here are Thursday's top research calls, including upgrades for Anadarko Petroleum, GrubHub and Merck, and a downgrade for Pfizer.